More recently, Zhu et al. reported that the HBx gene of hepatitis B virus (HBV) promotes the occurrence and development of liver cancer by up-regulating the expression of S100A4; therefore, the authors believe that S100A4 is a potential therapeutic target for HBV-induced liver cancer [56]. Here, S100A4 is linked to liver cancer.